These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

404 related items for PubMed ID: 20229688

  • 21. Thrombin activatable fibrinolysis inhibitor (TAFI)--how does thrombin regulate fibrinolysis?
    Bouma BN, Mosnier LO.
    Ann Med; 2006; 38(6):378-88. PubMed ID: 17008302
    [Abstract] [Full Text] [Related]

  • 22. Monoclonal antibodies targeting the antifibrinolytic activity of activated thrombin-activatable fibrinolysis inhibitor but not the anti-inflammatory activity on osteopontin and C5a.
    Semeraro F, Ammollo CT, Gils A, Declerck PJ, Colucci M.
    J Thromb Haemost; 2013 Dec; 11(12):2137-47. PubMed ID: 24134522
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Total thrombin-activatable fibrinolysis inhibitor (TAFI) antigen and pro-TAFI in patients with haemophilia A.
    Antovic J, Schulman S, Eelde A, Blombäck M.
    Haemophilia; 2001 Nov; 7(6):557-60. PubMed ID: 11851753
    [Abstract] [Full Text] [Related]

  • 26. A role for procarboxypepidase U (TAFI) in thrombosis.
    Willemse JL, Hendriks DF.
    Front Biosci; 2007 Jan 01; 12():1973-87. PubMed ID: 17127436
    [Abstract] [Full Text] [Related]

  • 27. Selective modulation of thrombin-activatable fibrinolysis inhibitor (TAFI) activation by thrombin or the thrombin-thrombomodulin complex using TAFI-derived peptides.
    Plug T, Marquart JA, Marx PF, Meijers JC.
    J Thromb Haemost; 2015 Nov 01; 13(11):2093-101. PubMed ID: 26341360
    [Abstract] [Full Text] [Related]

  • 28. Thrombin and fibrinolysis.
    Nesheim M.
    Chest; 2003 Sep 01; 124(3 Suppl):33S-9S. PubMed ID: 12970122
    [Abstract] [Full Text] [Related]

  • 29. Thrombin-activable fibrinolysis inhibitor zymogen does not play a significant role in the attenuation of fibrinolysis.
    Foley JH, Kim P, Nesheim ME.
    J Biol Chem; 2008 Apr 04; 283(14):8863-7. PubMed ID: 18252711
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Reduced activity of TAFI (thrombin-activatable fibrinolysis inhibitor) in acute promyelocytic leukaemia.
    Meijers JC, Oudijk EJ, Mosnier LO, Bos R, Bouma BN, Nieuwenhuis HK, Fijnheer R.
    Br J Haematol; 2000 Mar 04; 108(3):518-23. PubMed ID: 10759708
    [Abstract] [Full Text] [Related]

  • 33. Thrombin Activatable Fibrinolysis Inhibitor (TAFI): An Updated Narrative Review.
    Sillen M, Declerck PJ.
    Int J Mol Sci; 2021 Apr 01; 22(7):. PubMed ID: 33916027
    [Abstract] [Full Text] [Related]

  • 34. Effect of warfarin treatment on thrombin activatable fibrinolysis inhibitor (TAFI) activation and TAFI-mediated inhibition of fibrinolysis.
    Incampo F, Carrieri C, Galasso R, Scaraggi FA, Di Serio F, Woodhams B, Semeraro N, Colucci M.
    J Thromb Haemost; 2013 Feb 01; 11(2):315-24. PubMed ID: 23256818
    [Abstract] [Full Text] [Related]

  • 35. Identification of a thrombomodulin interaction site on thrombin-activatable fibrinolysis inhibitor that mediates accelerated activation by thrombin.
    Marar TT, Boffa MB.
    J Thromb Haemost; 2016 Apr 01; 14(4):772-83. PubMed ID: 26816270
    [Abstract] [Full Text] [Related]

  • 36. Structure-function relationships in thrombin-activatable fibrinolysis inhibitor.
    Plug T, Meijers JC.
    J Thromb Haemost; 2016 Apr 01; 14(4):633-44. PubMed ID: 26786060
    [Abstract] [Full Text] [Related]

  • 37. Regulation of fibrinolysis by thrombin activatable fibrinolysis inhibitor, an unstable carboxypeptidase B that unites the pathways of coagulation and fibrinolysis.
    Mosnier LO, Bouma BN.
    Arterioscler Thromb Vasc Biol; 2006 Nov 01; 26(11):2445-53. PubMed ID: 16960106
    [Abstract] [Full Text] [Related]

  • 38. Thrombin activatable fibrinolysis inhibitor (TAFI) does not inhibit in vitro thrombolysis by pharmacological concentrations of t-PA.
    Colucci M, D'Aprile AM, Italia A, Gresele P, Morser J, Semeraro N.
    Thromb Haemost; 2001 Apr 01; 85(4):661-6. PubMed ID: 11341502
    [Abstract] [Full Text] [Related]

  • 39. Reduced fibrinolytic resistance in patients with factor XI deficiency. Evidence of a thrombin-independent impairment of the thrombin-activatable fibrinolysis inhibitor pathway.
    Colucci M, Incampo F, Cannavò A, Menegatti M, Siboni SM, Zaccaria F, Semeraro N, Peyvandi F.
    J Thromb Haemost; 2016 Aug 01; 14(8):1603-14. PubMed ID: 27094709
    [Abstract] [Full Text] [Related]

  • 40. Activated thrombin-activatable fibrinolysis inhibitor attenuates the angiogenic potential of endothelial cells: potential relevance to the breast tumour microenvironment.
    Bazzi ZA, Balun J, Cavallo-Medved D, Porter LA, Boffa MB.
    Clin Exp Metastasis; 2017 Feb 01; 34(2):155-169. PubMed ID: 28124276
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.